The proper characterization of protein-ligand interfaces is essential for structural biology, with implications ranging from the fundamental understanding of biological processes to pharmacology. Nuclear magnetic resonance is a powerful technique for such studies. We propose a novel approach to the direct determination of the likely pose of a peptide ligand onto a protein partner, by using freq...

In the Arabidopsis thaliana genome, over 1000 putative genes encoding small, presumably secreted, signalling peptides can be recognized. However, a major obstacle in identifying the function of genes encoding small signalling peptides is the limited number of available loss-of-function mutants. To overcome this, a promising new tool, antagonistic peptide technology, was recently developed. Here...

abstract background antibiotic resistance makes antimicrobial peptides (amps) agents an alternative for treatment of pathogenic diseases. they are isolated from various animals invertebrates, vertebrates and plants. the present study shows the electrophoretic pattern of protein and peptides from vicia faba seed and reports our first attempt to study the antibacterial activity of vicia faba seed...

Peptide ligands have played an important role in tumor-targeted drug delivery as targeting moieties. The in vivo fate of peptide-mediated drug delivery systems and the following antitumor effects may greatly depend on the stability of the peptide ligand. In the current study, a tumor-targeting cyclic peptide screened by phage display, Lyp-1 (a peptide that specifically binds to tumor and endoth...

The recent crystal structure of Pin1 protein bound to a doubly phosphorylated peptide from the C-terminal domain of RNA polymerase II revealed that binding interactions between Pin1 and its substrate take place through its Trp-Trp (WW) domain at the level of the loop Ser(11)-Arg(12) and the aromatic pair Tyr(18)-Trp(29), and showed a trans conformation for both pSer-Pro peptide bonds. However, ...

THE INFLUENZA/H1N1 VIRUS HAS CAUSED HAZARD IN THE PUBLIC HEALTH OF MANY COUNTRIES. HENCE, EXISTING INFLUENZA DRUGS COULD NOT COPE WITH H1N1 INFECTION DUE TO THE HIGH MUTATION RATE OF THE VIRUS. IN THIS RESPECT, NEW METHOD TO BLOCK THE VIRUS WAS DEVISED. THE POLYMERASE PAC-PB1N ENZYME IS RESPONSIBLE FOR THE REPLICATION OF H1N1 VIRUS. THUS, NOVEL INHIBITORS WERE DEVELOPED TO WARD OFF THE FUNCTION...